Respicardia
Latest round
- Series D
Last raised
- Oct 2014
Total raised
- $83M
Investors
- 8
About Respicardia
Respicardia, Inc.Founded in 2006 in Minnetonka, US, Respicardia, Inc. is dedicated to addressing central sleep apnea (CSA)., with financial terms undisclosed. The company has engaged in a total of 8 deals since inception.Respicardia, Inc. develops the rem ede® System, an implantable phrenic nerve stimulator designed to treat moderate to severe central sleep apnea in adults. This system uniquely functions without traditional masks or medications, automatically restoring normal breathing patterns during sleep. It is primarily available in the United States and select international markets, including parts of Europe that recognize the CE Mark certification.Respicardia, Inc. generates revenue through the sales of the rem ede® System and related medical devices, primarily via direct-to-consumer and business-to-business transactions. The revenue model involves sales to hospitals, clinics, and sleep disorder centers, where healthcare providers prescribe and implant the device. Following successful implantation, healthcare providers also offer follow-up services, enhancing the value of the initial transaction.Following the acquisition by ZOLL Medical Corporation in April 2021, Respicardia, Inc. is poised for strategic growth. The company plans to leverage new resources to enhance product design and expand its market presence. Specific plans include the development of new products aimed at improving the treatment of CSA and targeting expansion into additional international markets.
Who invested in Respicardia
8 investors across 4 rounds
See all investors in Respicardia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Respicardia
Who invested in Respicardia?
Respicardia has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Respicardia raised?
Respicardia has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Respicardia last raise money?
Respicardia's most recent round on record is a Series D, in Oct 2014.
What does Respicardia do?
Respicardia is a medical devices & equipment company.
Where is Respicardia headquartered?
Respicardia is headquartered in Minnetonka, US.
Which VCs invest in companies like Respicardia?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Respicardia's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Respicardia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.